Fractional light-based technology licensing
This article was originally published in The Gray Sheet
Executive Summary
Palomar Medical Technologies and Reliant Technologies form Fractional Technology Open Patent Program to out-license intellectual property and encourage further development of fractional light-based products by others in the industry, the firms announce Nov. 11. The initiative includes six fractional patent families owned or controlled by Palomar, Reliant and Massachusetts General Hospital. Palomar and Reliant note that they also have entered into certain cross-license agreements. Fractional technology is used in dermatology procedures to deliver laser or high-powered light energy to the skin in a pattern that leaves untreated areas between the treated areas. Reliant's pending merger with aesthetic device maker Thermage is set to close in the fourth quarter (1"The Gray Sheet" July 14, 2008, p. 11)
You may also be interested in...
Thermage Bolsters Aesthetic Skin Treatment Offerings Via Reliant Purchase
Aesthetic device maker Thermage will market its ThermaCool radiofrequency energy-based skin tightening treatment alongside Fraxel laser-based skin resurfacing systems made by Reliant Technologies after acquiring the firm for $95 million in a deal announced July 7
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.